| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/06/2002 | WO2002067861A2 Oncolytic adenoviral vectors |
| 09/06/2002 | WO2002067856A2 Injection molding of living tissues |
| 09/06/2002 | WO2002067762A2 Muscle-polymer constructs for bone tissue engineering |
| 09/06/2002 | WO2002067692A1 Ruminal fluid inoculation of calves |
| 09/06/2002 | WO2002047712A3 Peptide yy and peptide yy agonists for treatment of metabolic disorders |
| 09/06/2002 | WO2002040049A3 Blockade of t cell migration into epithelial gvhd target tissues |
| 09/06/2002 | WO2002040042A3 Method for optimally delivering virus to a solid tumor mass |
| 09/06/2002 | WO2002034889A3 Therapeutic uses for mesenchymal stromal cells |
| 09/06/2002 | WO2002010348A3 Tissue implant for cartilage repair |
| 09/06/2002 | WO2002010217A3 Endothelial cell expression patterns |
| 09/06/2002 | WO2001092479A3 Method to determine the differentiation potential of a target cell |
| 09/06/2002 | WO2001073093A3 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 09/06/2002 | WO2001072822B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001023531A9 Recognition of differences in cell cycle structure between stem and differentiated cells |
| 09/06/2002 | WO2001018035A9 Muc-1 derived peptides |
| 09/06/2002 | WO2001014581A9 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 09/06/2002 | WO2001012674A9 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 09/06/2002 | WO2001012236A9 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 09/06/2002 | WO2001007059A9 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 09/06/2002 | WO2001005944A9 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 09/06/2002 | WO2000067761A9 Compositions and methods for identifying antigens which elicit an immune response |
| 09/06/2002 | CA2756609A1 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 09/06/2002 | CA2674673A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2439335A1 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 09/06/2002 | CA2439297A1 Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues |
| 09/06/2002 | CA2439185A1 Vector constructs |
| 09/06/2002 | CA2439168A1 Modified thrombopoietin with reduced immunogenicity |
| 09/06/2002 | CA2439115A1 Novel oncolytic adenoviral vectors |
| 09/06/2002 | CA2438934A1 Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp |
| 09/06/2002 | CA2438899A1 Method for determining efficacy of reverse cholesterol transport enhancing agents |
| 09/06/2002 | CA2437530A1 Symbiotic regenerative agent |
| 09/06/2002 | CA2437218A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2435848A1 Method for purifying a biological composition |
| 09/06/2002 | CA2434671A1 Methods and compositions for modulating regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor |
| 09/06/2002 | CA2430702A1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/05/2002 | US20020124277 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 09/05/2002 | US20020123615 Quality improvement for animal whole blood protein products |
| 09/05/2002 | US20020123614 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 09/05/2002 | US20020123481 C-fos induced growth factor (FIGF) and DNA encoding same |
| 09/05/2002 | US20020123147 Gene transfer with adenoviruses having modified fiber proteins |
| 09/05/2002 | US20020123143 Cellular composition for use in the treatment and repair of bone and nervous system disorders |
| 09/05/2002 | US20020123142 Generating cell culture; obtain cells, deposit on dextran beadlets, culture, separate cells from beadlets by digestion with dextranase |
| 09/05/2002 | US20020123141 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 09/05/2002 | US20020123119 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides and for treatment and prevention of infections |
| 09/05/2002 | US20020123102 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of thyroid defcets |
| 09/05/2002 | US20020123099 Highly expressible genes |
| 09/05/2002 | US20020123093 Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia |
| 09/05/2002 | US20020123047 dexB |
| 09/05/2002 | US20020123030 Deactivating a viral sample; obtain sample containing virus, incubate with quenching agent, separate viral particles from sample fluid |
| 09/05/2002 | US20020122791 Antigenic CK-18 compounds for therapy and diagnosis and methods for using same |
| 09/04/2002 | EP1236463A1 Topical cosmetic composition |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |
| 09/04/2002 | EP1235912A2 Tumour-specific vector for gene therapy |
| 09/04/2002 | EP1235902A1 Olfactory ensheathing cells isolated from the lamina propria |
| 09/04/2002 | EP1235901A2 Method and compositions for producing cell transplants |
| 09/04/2002 | EP1235900A1 Microparticle-based transfection and activation of dendritic cells |
| 09/04/2002 | EP1235899A1 Treatment of human infertility |
| 09/04/2002 | EP1235858A1 Use of the insulin-like-growth factor i isoform mgf for the treatment of neurological disorders |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235590A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 09/04/2002 | EP1235485A2 Lung stem cells and lung regeneration |
| 09/04/2002 | EP0755443B1 Tissue-specific enhancer active in prostate |
| 09/04/2002 | EP0711355B1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 09/04/2002 | EP0711171B1 A pharmaceutical or cosmetic composition comprising a colostrum fraction and its medical use |
| 09/04/2002 | EP0702723B1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 09/04/2002 | CN1367830A Cancer associated antigens and uses therefor |
| 09/04/2002 | CN1367829A Compositions and methods for therapy and diagnosis of lung cancer |
| 09/04/2002 | CN1367826A Method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 09/04/2002 | CN1367790A Moraxella cattarrhalis BASB114 polypeptide antigens and uses thereof |
| 09/04/2002 | CN1367235A Black ant liquor and its preparation method |
| 09/04/2002 | CN1367178A Technological process for extracting and purifying deer's fetus extract |
| 09/04/2002 | CN1367016A Compound preparation for curing diarrhea |
| 09/04/2002 | CN1367004A Medicine for curing cancers |
| 09/04/2002 | CN1367003A Medicine for curing AIDS |
| 09/04/2002 | CN1367000A Chinese patent medicine for acute and chronic renal failure and preparation method |
| 09/04/2002 | CN1366998A Lutai oral liquor |
| 09/04/2002 | CN1366992A Medicine for external application for curing scald and burn, its production method and application |
| 09/04/2002 | CN1366991A Application of plant extract for preparing medicine to cure bone absorption increment diseases |
| 09/04/2002 | CN1366985A Blood pressure reducing plaster |
| 09/04/2002 | CN1366886A Liquor for curing hemorrhagic coliinfection |
| 09/04/2002 | CN1366885A Bee product composition for curing diabetes and its preparation method |
| 09/04/2002 | CN1090028C Medicine for treatment of restenosis and arteriosclerosis |
| 09/04/2002 | CN1090027C Immunity-strengthening and infection-preventing medicine |
| 09/04/2002 | CN1090026C Novel medicine for stopping narcotics and preparing method thereof |
| 09/04/2002 | CN1090025C Medicated wine for treating pain in waist and lower extremities and rheumatic arthritis, and its producing method |
| 09/04/2002 | CN1090024C Method for preparation of medicine capable of improving sexual function, enhancing immunity and removing fatigue |
| 09/04/2002 | CN1090023C Method for production of solid tea fungus active medicinal preparation |
| 09/04/2002 | CN1090022C Cancer treatment by photodynamic therapy, in combination with immunoadjuvant |
| 09/03/2002 | US6444871 Expression vector for use in the treatment and prevention of viral diseases |
| 09/03/2002 | US6444800 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 09/03/2002 | US6444651 Antimicrobial agents for eucaryotic microorganisms and methods of growth suppression of eucaryotic microorganisms using these agents |
| 09/03/2002 | US6444418 Plasma-like solution |
| 09/03/2002 | US6444236 Blood circulation |
| 09/03/2002 | US6444229 Enzymatically digested submucosa of a warm-blooded vertebrate gelled into a shape retaining gel matrix for inducing cell proliferation and growth both in vivo and in vitro; extracellular matrix |
| 09/03/2002 | US6444207 Binding with epitope of antigen; anticancer agents |
| 09/03/2002 | US6444205 Transplantation of neural cells for the treatment of chronic pain or spasticity |
| 09/03/2002 | US6444203 Administering bacteria to improve sleep |
| 09/03/2002 | CA2232985C Methods for treating cancers and restenosis with p21 |
| 09/03/2002 | CA2093557C Antimicrobial composition |